← Leaderboards
Rebecca Li
New England Research Institutes, Inc.
$7,878,488
Attributed
$7,878,488
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.4M · FY2009–14$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$7,878,488 · 1
By mechanism
N01$7,878,488 · 1
Top collaborators
No co-investigators on record.
Most similar at New England Research Institutes, Inc.
Same institution · by research overlap
- Mary Jo Larson$11,366,879
- John B McKinlay$35,709,504
- Lynn A Sleeper$12,494,891
- Karen Lutfey Spencer$1,482,819
- Sonja M McKinlay$19,814,759
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultAldosterone AntagonistsAmericanAmerican Heart AssociationAnalogAtrial FibrillationBloodCardiologyCardiomyopathiesCardiovascular SystemCaringCitiesClinical DiagnosisCollegeDeteriorationDiabetes MellitusDoseDouble-Blind Placebo Controlled TrialEnrollmentEuropeanEvaluationEventFollow-UpAccounting
Grant awards (3)
Treatment of Preserved Systolic Function with an Aldosterone Antagonist$998,642
N01 · FY2014 · HL · contact PI
Treatment of Preserved Systolic Function with an Aldosterone Antagonist$2,472,282
N01 · FY2013 · HL · contact PI
Treatment of Preserved Systolic Function with an Aldosterone Antagonist$4,407,564
N01 · FY2009 · HL · contact PI